跳至主要内容
临床试验/DRKS00021415
DRKS00021415招募中不适用

Prediction of hematotoxicity and non-hematological toxicity of systemic therapies and other clinical outcome parameters for patients with locally advanced gastric cancer or gastroesophageal transition (AEG I-III by Siewert) and patients with pancreatic carcinoma

niversitäres Krebszentrum Leipzig (UCCL)0 个研究点目标入组 35 人开始时间: 2020年4月30日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients with locally advanced carcinoma of the stomach, gastroesophageal transition (AEG I-III by Siewert) or pancreas receiving systemic chemotherapy, signed consent form, legal age (= 18 years)

排除标准

  • Minority (< 18 years), missing consent form, presence of pronounced anemia (the hemoglobin value of <=4.6 mmol/l serves as a guideline), pregnant and nursing patients

研究者

发起方
niversitäres Krebszentrum Leipzig (UCCL)

相似试验